Benefits of utilizing gene-modified iPSCs for clinical applications

James Ellis, Christopher Baum, Nissim Benvenisty, Gustavo Mostoslavsky, Hideyuki Okano, William L. Stanford, Matthew Porteus, Michel Sadelain

研究成果: Letter

17 引用 (Scopus)
元の言語English
ページ(範囲)429-430
ページ数2
ジャーナルCell stem cell
7
発行部数4
DOI
出版物ステータスPublished - 2010 10 8

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

これを引用

Ellis, J., Baum, C., Benvenisty, N., Mostoslavsky, G., Okano, H., Stanford, W. L., Porteus, M., & Sadelain, M. (2010). Benefits of utilizing gene-modified iPSCs for clinical applications. Cell stem cell, 7(4), 429-430. https://doi.org/10.1016/j.stem.2010.09.010